Promising Dual Immunotherapy for Anaplastic Thy...

By Rene Pretorius

January 10, 2025

We review the results from the phase 2 nonrandomized clinical trial on the clinical activity of dual immune checkpoint inhibition in aggressive thyroid cancer. The purpose of the study was to...
Valuable, Cost-Effective Thyroid Cancer Diagnosis
WHO Prequalifies First G6PD Diagnostic Test
Diabetes Drugs Safe from Thyroid Cancer Risk, Study Finds
Abu Dhabi Introduces WINREVAIR: A Major Breakthrough in Pulmonary Arterial Hy...
Thyroid Eye Disease Therapy: Insights from Viridian Therapeutics’ THRIV...
Transforming Cancer Care in Abu Dhabi
Promising Results for Imlunestrant in Advanced ER+ HER2- Breast Cancer
Heplisav-B: A Superior Hepatitis B Vaccine for Individuals with HIV
Advancing the 95-95-95 Targets: A Roadmap to End AIDS by 2030
Enhancing Access to Innovative Medicines: WHO’s Updated Guidance on Adv...
Zepbound Outperforms Wegovy in Weight Loss Trial
Dark Chocolate: A Sweet Ally Against Type 2 Diabetes and More